BG Tehan, A Bortolato, FE Blaney, MP Weir… - Pharmacology & …, 2014 - Elsevier
Several new pairs of active and inactive GPCR structures have recently been solved enabling detailed structural insight into the activation process, not only of rhodopsin but now …
N Plattner, F Noé - Nature communications, 2015 - nature.com
Understanding the structural mechanisms of protein–ligand binding and their dependence on protein sequence and conformation is of fundamental importance for biomedical …
Understanding and control of structures and rates involved in protein ligand binding are essential for drug design. Unfortunately, atomistic molecular dynamics (MD) simulations …
Adenosine A2A receptor (A2AR)-dopamine D2 receptor (D2R) heteromers are key modulators of striatal neuronal function. It has been suggested that the psychostimulant …
Highlights•Nanobodies lock distinct conformational states of proteins.•Nanobodies stabilize protein complexes.•Nanobodies can be functionally expressed as intrabodies to study …
A Mori, JF Chen, S Uchida, C Durlach, SM King… - Molecules, 2022 - mdpi.com
The adenosine A2A receptor subtype is recognized as a non-dopaminergic pharmacological target for the treatment of neurodegenerative disorders, notably …
Background It has been hypothesized that heteromers of adenosine A 2A receptors (A2AR) and cannabinoid CB 1 receptors (CB1R) localized in glutamatergic nerve terminals mediate …
F Magnani, MJ Serrano-Vega, Y Shibata… - Nature protocols, 2016 - nature.com
The thermostability of an integral membrane protein (MP) in detergent solution is a key parameter that dictates the likelihood of obtaining well-diffracting crystals that are suitable for …
A Mori - Parkinsonism & related disorders, 2020 - Elsevier
Adenosine A 2A receptor antagonism is a new therapeutic strategy in the symptomatic treatment of Parkinson's disease (PD). This review addresses how adenosine A 2A …